Skip to main content

Table 3 Adjusted relative risks for Death and Loss to Follow up during TB treatment compared to favorable TB treatment outcomes

From: Is distance associated with tuberculosis treatment outcomes? A retrospective cohort study in Kampala, Uganda

 DeathLost to Follow Up
Adjusted RR (95% CI)Adjusted RR (95% CI)
Euclidean Distance
  < 2 kmReferenceReference
 2 to < 5 km1.48 (0.99, 2.22)0.59 (0.38, 0.89)
 5 to < 10 km1.38 (0.90, 2.12)0.61 (0.39, 0.95)
  > 10 km1.35 (0.86, 2.10)0.45 (0.25, 0.81)
Age at diagnosis
 0–14 years0.59 (0.24, 1.46)0.28 (0.07, 1.12)
 15–24 years0.59 (0.30, 1.14)0.80 (0.53, 1.22)
 25–34 yearsReferenceReference
 35–44 years1.38 (0.94, 2.02)0.65 (0.42, 0.99)
 45–54 years1.68 (1.11, 2.54)0.64 (0.36, 1.12)
 55–64 years2.08 (1.23, 3.51)0.51 (0.16, 1.58)
  > 65 years6.44 (3.69, 11.27)0.77 (0.20, 3.02)
Male sex0.98 (0.74, 1.31)1.31 (0.94, 1.83)
HIV Positive3.28 (2.23, 4.81)1.05 (0.73, 1.51)
Pulmonary TB0.93 (0.66, 1.30)1.50 (0.78, 2.86)
Lack of bacteriological confirmation2.14 (1.59, 2.89)1.45 (0.99, 2.13)
Treatment Start year
 2014ReferenceReference
 20150.78 (0.55, 1.10)0.88 (0.61, 1.26)
 20160.81 (0.59, 1.13)0.88 (0.61, 1.27)
Facility
 Kisugu Health Center (public)ReferenceReference
 Alive Medical Services1.02 (0.63, 1.66)1.10 (0.74, 1.62)
 International Hospital Kampala1.41 (0.83, 2.39)0.60 (0.34, 1.08)
 Kibuli Muslim Hospital1.48 (0.90, 2.44)0.83 (0.49, 1.41)
 St. Francis Hospital - Nsambya0.92 (0.59, 1.45)0.25 (0.14, 0.46)
 Meeting Point1.72 (0.51, 5.77)excluded
  1. Meeting Point reported no patients lost to follow up